217 related articles for article (PubMed ID: 32329416)
21. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
[TBL] [Abstract][Full Text] [Related]
22. Node-based learning of differential networks from multi-platform gene expression data.
Ou-Yang L; Zhang XF; Wu M; Li XL
Methods; 2017 Oct; 129():41-49. PubMed ID: 28579401
[TBL] [Abstract][Full Text] [Related]
23. Gene regulatory network from microarray data of colon cancer patients using TSK-type recurrent neural fuzzy network.
Vineetha S; Chandra Shekara Bhat C; Idicula SM
Gene; 2012 Sep; 506(2):408-16. PubMed ID: 22759510
[TBL] [Abstract][Full Text] [Related]
24. Gene expression signature predicts radiation sensitivity in cell lines using the integral of dose-response curve.
Kolnohuz A; Ebrahimpour L; Yolchuyeva S; Manem VSK
BMC Cancer; 2024 Jan; 24(1):2. PubMed ID: 38166789
[TBL] [Abstract][Full Text] [Related]
25. Inferences of individual drug responses across diverse cancer types using a novel competing endogenous RNA network.
Zhang Y; Li X; Zhou D; Zhi H; Wang P; Gao Y; Guo M; Yue M; Wang Y; Shen W; Ning S; Li Y; Li X
Mol Oncol; 2018 Sep; 12(9):1429-1446. PubMed ID: 29464864
[TBL] [Abstract][Full Text] [Related]
26. Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer.
Speers C; Zhao S; Liu M; Bartelink H; Pierce LJ; Feng FY
Clin Cancer Res; 2015 Aug; 21(16):3667-77. PubMed ID: 25904749
[TBL] [Abstract][Full Text] [Related]
27. Identification of a 5‑microRNA signature and hub miRNA‑mRNA interactions associated with pancreatic cancer.
Ma X; Tao R; Li L; Chen H; Liu Z; Bai J; Shuai X; Wu C; Tao K
Oncol Rep; 2019 Jan; 41(1):292-300. PubMed ID: 30365134
[TBL] [Abstract][Full Text] [Related]
28. Inferring regulatory networks.
Li H; Xuan J; Wang Y; Zhan M
Front Biosci; 2008 Jan; 13():263-75. PubMed ID: 17981545
[TBL] [Abstract][Full Text] [Related]
29. Identifying differential networks based on multi-platform gene expression data.
Ou-Yang L; Yan H; Zhang XF
Mol Biosyst; 2016 Dec; 13(1):183-192. PubMed ID: 27868129
[TBL] [Abstract][Full Text] [Related]
30. Fused Regression for Multi-source Gene Regulatory Network Inference.
Lam KY; Westrick ZM; Müller CL; Christiaen L; Bonneau R
PLoS Comput Biol; 2016 Dec; 12(12):e1005157. PubMed ID: 27923054
[TBL] [Abstract][Full Text] [Related]
31. Prediction of radiosensitive patients with gastric cancer by developing gene signature.
Zhou J; Wu X; Li G; Gao X; Zhai M; Chen W; Hu H; Tang Z
Int J Oncol; 2017 Oct; 51(4):1067-1076. PubMed ID: 28902346
[TBL] [Abstract][Full Text] [Related]
32. Inference of radio-responsive gene regulatory networks using the graphical lasso algorithm.
Oh JH; Deasy JO
BMC Bioinformatics; 2014; 15 Suppl 7(Suppl 7):S5. PubMed ID: 25077716
[TBL] [Abstract][Full Text] [Related]
33. Prediction of chemo-response in serous ovarian cancer.
Gonzalez Bosquet J; Newtson AM; Chung RK; Thiel KW; Ginader T; Goodheart MJ; Leslie KK; Smith BJ
Mol Cancer; 2016 Oct; 15(1):66. PubMed ID: 27756408
[TBL] [Abstract][Full Text] [Related]
34. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
[TBL] [Abstract][Full Text] [Related]
35. Development of a radiosensitivity gene signature for patients with soft tissue sarcoma.
Tang Z; Zeng Q; Li Y; Zhang X; Ma J; Suto MJ; Xu B; Yi N
Oncotarget; 2017 Apr; 8(16):27428-27439. PubMed ID: 28404969
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of protein interactome networks prioritizes candidate genes with cancer signatures.
Li Y; Sahni N; Yi S
Oncotarget; 2016 Nov; 7(48):78841-78849. PubMed ID: 27791983
[TBL] [Abstract][Full Text] [Related]
37. A new multiple regression approach for the construction of genetic regulatory networks.
Zhang SQ; Ching WK; Tsing NK; Leung HY; Guo D
Artif Intell Med; 2010; 48(2-3):153-60. PubMed ID: 19963359
[TBL] [Abstract][Full Text] [Related]
38. A network approach to quantifying radiotherapy effect on cancer: Radiosensitive gene group centrality.
Yao YX; Bing ZT; Huang L; Huang ZG; Lai YC
J Theor Biol; 2019 Feb; 462():528-536. PubMed ID: 30521864
[TBL] [Abstract][Full Text] [Related]
39. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
[TBL] [Abstract][Full Text] [Related]
40. Tumour and normal tissue radiosensitivity.
Lapierre A; Gourgou S; Brengues M; Quéro L; Deutsch É; Milliat F; Riou O; Azria D
Cancer Radiother; 2022; 26(1-2):96-103. PubMed ID: 34953704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
